BeranA, SrourO, MalhasSE, MhannaM, AyeshH, SajdeyaO, et al. High-flow nasal cannula versus noninvasive ventilation in patients with COVID-19. Respir Care, 2022; 67(9):1177-1189.
2.
GriecoDL, MengaLS, CesaranoM, RosàT, SpadaroS, BitondoMM, et al. COVID-ICU Gemelli Study Group. Effect of helmet noninvasive ventilation vs high-flow nasal oxygen on days free of respiratory support in patients with COVID-19 and moderate to severe hypoxemic respiratory failure: the HENIVOT randomized clinical trial. JAMA, 2021; 325(17):1731-1743.
3.
NairPR, HarithaD, BeheraS, KayinaCA, MaitraS, AnandRK, et al. Comparison of high-flow nasal cannula and noninvasive ventilation in acute hypoxemic respiratory failure due to severe COVID-19 pneumonia. Respir Care, 2021; 66(12):1824-1830.
4.
MuradMH, AsiN, AlsawasM, AlahdabF. New evidence pyramid. Evid Based Med, 2016; 21(4):125-127.
5.
TomlinG, BorgettoB. Research pyramid: a new evidence-based practice model for occupational therapy. Am J Occup Ther, 2011; 65(2):189-196.
6.
BellomoR, WarrillowSJ, ReadeMC. Why we should be wary of single-center trials. Crit Care Med, 2009; 37(12):3114-3119.
7.
BafetaA, DechartresA, TrinquartL, YavchitzA, BoutronI, RavaudP. Impact of single-center status on estimates of intervention effects in trials with continuous outcomes: meta-epidemiological study. BMJ, 2012; 344:e813.
8.
BerelowitzKS, WolfC, TäubelJ. Benefits of a single- versus multi-center approach in early-phase patient studies a case study of multiple sclerosis patients. New Horiz Clin Res, 2011; 25:21-25.
9.
ChanAW, AltmanDG. Identifying outcome reporting bias in randomized trials on PubMed: review of publications and survey of authors. BMJ, 2005; 330(7494):753.
10.
ChanAW, Krleza-JerićK, SchmidI, AltmanDG. Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research. CMAJ, 2004; 171(7):735-740.
11.
SchulzKF, AltmanDG, MoherD. CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. BMJ, 2010; 340:c332.
12.
MoherD, SchulzKF, AltmanDG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Lancet, 2001; 357(9263):1191-1194.
13.
TurnerL, MoherD, ShamseerL, WeeksL, PetersJ, PlintA, et al. The influence of CONSORT on the quality of reporting of randomized controlled trials: an updated review. Trials, 2011; 12(S1)A47.
14.
De AngelisCD, DrazenJM, FrizelleFA, HaugC, HoeyJ, HortonR, et al. International Committee of Medical Journal Editors. Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors. Lancet, 2005; 365(9474):1827-1829.
ZarinDA, KeselmanA. Registering a clinical trial in ClinicalTrials.gov. Chest, 2007; 131(3):909-912.
17.
ElliottTR. Registering randomized clinical trials and the case for CONSORT. Exp Clin Psychopharmacol, 2007; 15(6):511-518.
18.
SpeichB, GloyVL, KlatteK, GryaznovD, TajiHeravi A, GhoshN, et al. Adherence to Spirit Recommendations (ASPIRE) Study Group. Reliability of trial information across registries for trials with multiple registrations: a systematic review. JAMA Netw Open, 2021; 4(11):e2128898.
SchulzKF, ChalmersI, HayesRJ, AltmanDG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA, 1995; 273(5):408-412.
21.
MoustgaardH, ClaytonGL, JonesHE, BoutronI, JørgensenL, LaursenDRT, et al. Impact of blinding on estimated treatment effects in randomized clinical trials: meta-epidemiological study. BMJ, 2020; 368:l6802.
22.
BalkEM, BonisPA, MoskowitzH, SchmidCH, IoannidisJP, WangC, et al. Correlation of quality measures with estimates of treatment effect in meta-analyses of randomized controlled trials. JAMA, 2002; 287(22):2973-2982.
23.
SavovićJ, JonesHE, AltmanDG, HarrisRJ, JüniP, PildalJ, et al. Influence of reported study design characteristics on intervention effect estimates from randomized controlled trials. Ann Intern Med, 2012; 157(6):429-438.
24.
SkellyAC, DettoriJR, BrodtED. Assessing bias: the importance of considering confounding. Evid Based Spine Care J, 2012; 3(1):9-12.
LiJ, LuoJ, PavlovI, PerezY, TanW, RocaO, et al. Awake prone positioning for non-intubated patients with COVID-19–related acute hypoxemic respiratory failure: a systematic review and meta-analysis. Lancet Respir Med, 2022; 10(6):573-583.
27.
JagerKJ, ZoccaliC, MacleodA, DekkerFW. Confounding: what it is and how to deal with it. Kidney Int, 2008; 73(3):256-260.
28.
FogelDB. Factors associated with clinical trials that fail and opportunities for improving the likelihood of success: a review. Contemp Clin Trials Commun, 2018; 11:156-164.
